Stockholders' Equity (Details) - USD ($)			3 Months Ended	8 Months Ended	9 Months Ended	12 Months Ended
	Oct. 02, 2020	May 21, 2020	Dec. 31, 2019	Aug. 31, 2020	Sep. 30, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 16, 2019	Dec. 09, 2019	Sep. 24, 2018	Sep. 25, 2017	Mar. 02, 2017
Debt Instrument [Line Items]
Stock Issued During Period, Shares, New Issues							13,382,196
Extinguishment of Debt, Amount						$ 11,200,000
Cash payment for repurchase of convertible notes				$ 18,845,000			$ 97,889,000	$ 0
Stock Repurchased During Period, Shares			31,000,000.0	12,322,988	8,700,000		26,321,293	16,660,566	13,300,000
Stock Repurchase Program, Authorized Amount										$ 75,000,000	$ 200,000,000	$ 100,000,000.0	$ 25,000,000.0	$ 30,000,000.0
Stock Repurchased During Period, Value			$ 100,000,000.0	$ 39,400,000				$ 25,000,000.0	$ 30,000,000.0
Treasury Stock Acquired, Average Cost Per Share			$ 3.22	$ 3.20				$ 2.86	$ 2.25
Repayments of Convertible Debt						12,000,000.0
Evofem [Member]
Debt Instrument [Line Items]
Common Stock Dividends (in shares)		0.11591985
LENSAR [Member]
Debt Instrument [Line Items]
Common Stock Dividends (in shares)	0.075879
December 2021 Notes [Member]
Debt Instrument [Line Items]
Extinguishment of Debt, Amount						2,200,000	$ 44,800,000
Cash payment for repurchase of convertible notes				$ 5,400,000
Payment for Debt Extinguishment or Debt Prepayment Cost						2,300,000	39,900,000
December 2024 Notes [Member]
Debt Instrument [Line Items]
Extinguishment of Debt, Amount				$ 10,500,000		1,000,000.0	74,600,000
Payment for Debt Extinguishment or Debt Prepayment Cost						$ 1,100,000	$ 58,000,000.0